Search

Paul A Baker

Examiner (ID: 6715)

Most Active Art Unit
2188
Art Unit(s)
2188, 2187
Total Applications
122
Issued Applications
115
Pending Applications
3
Abandoned Applications
4

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18071367 [patent_doc_number] => 11530189 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-20 [patent_title] => Carbamate compounds and methods of making and using same [patent_app_type] => utility [patent_app_number] => 17/195351 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44725 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17195351 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/195351
Carbamate compounds and methods of making and using same Mar 7, 2021 Issued
Array ( [id] => 17243406 [patent_doc_number] => 20210363149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF [patent_app_type] => utility [patent_app_number] => 17/184194 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 146890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -94 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184194 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/184194
PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF Feb 23, 2021 Abandoned
Array ( [id] => 18369260 [patent_doc_number] => 11649415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Oil-water compositions, methods, and uses thereof [patent_app_type] => utility [patent_app_number] => 17/177205 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8224 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177205 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/177205
Oil-water compositions, methods, and uses thereof Feb 16, 2021 Issued
Array ( [id] => 16885359 [patent_doc_number] => 20210171554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 17/176962 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21555 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 379 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176962 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176962
BENZOTHIOPHENE ESTROGEN RECEPTOR MODULATORS TO TREAT MEDICAL DISORDERS Feb 15, 2021 Abandoned
Array ( [id] => 17791971 [patent_doc_number] => 20220251062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => INHIBITORS OF BACTERIAL PASTA KINASES [patent_app_type] => utility [patent_app_number] => 17/172314 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/172314
Inhibitors of bacterial pasta kinases Feb 9, 2021 Issued
Array ( [id] => 17791971 [patent_doc_number] => 20220251062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => INHIBITORS OF BACTERIAL PASTA KINASES [patent_app_type] => utility [patent_app_number] => 17/172314 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172314 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/172314
Inhibitors of bacterial pasta kinases Feb 9, 2021 Issued
Array ( [id] => 16854857 [patent_doc_number] => 20210155602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => TETRAHYDROQUINOLINO DERIVATIVES FOR THE TREATMENT OF METASTATIC AND CHEMORESISTANT CANCERS [patent_app_type] => utility [patent_app_number] => 17/162827 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162827 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/162827
TETRAHYDROQUINOLINO DERIVATIVES FOR THE TREATMENT OF METASTATIC AND CHEMORESISTANT CANCERS Jan 28, 2021 Pending
Array ( [id] => 19119982 [patent_doc_number] => 11963943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Formulation for pain management [patent_app_type] => utility [patent_app_number] => 17/162903 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 33 [patent_no_of_words] => 18371 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162903 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/162903
Formulation for pain management Jan 28, 2021 Issued
Array ( [id] => 16855232 [patent_doc_number] => 20210155977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => COUMARIN COMPOUNDS AND THEIR USES AS FLUORESCENT LABELS [patent_app_type] => utility [patent_app_number] => 17/162606 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16750 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -64 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17162606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/162606
Coumarin compounds and their uses as fluorescent labels Jan 28, 2021 Issued
Array ( [id] => 16837820 [patent_doc_number] => 20210145832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/159674 [patent_app_country] => US [patent_app_date] => 2021-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17159674 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/159674
TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE Jan 26, 2021 Abandoned
Array ( [id] => 17680951 [patent_doc_number] => 11365190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-21 [patent_title] => Heterocyclic amides useful as protein modulators [patent_app_type] => utility [patent_app_number] => 17/156893 [patent_app_country] => US [patent_app_date] => 2021-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87924 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156893 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/156893
Heterocyclic amides useful as protein modulators Jan 24, 2021 Issued
Array ( [id] => 17034930 [patent_doc_number] => 20210251888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => READY TO USE LIQUID FORMULATION [patent_app_type] => utility [patent_app_number] => 17/147953 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9474 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147953 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/147953
Ready to use liquid formulation Jan 12, 2021 Issued
Array ( [id] => 17036655 [patent_doc_number] => 20210253613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => PHOSPHORUS IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/145300 [patent_app_country] => US [patent_app_date] => 2021-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17137 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/145300
Phosphorus imidazoquinoline amine derivatives, pharmaceutical compositions and therapeutic methods thereof Jan 8, 2021 Issued
Array ( [id] => 16990112 [patent_doc_number] => 20210228532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => Neurodevelopmental Disorder Therapy [patent_app_type] => utility [patent_app_number] => 17/145073 [patent_app_country] => US [patent_app_date] => 2021-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17145073 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/145073
Neurodevelopmental disorder therapy Jan 7, 2021 Issued
Array ( [id] => 16807778 [patent_doc_number] => 20210130331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS [patent_app_type] => utility [patent_app_number] => 17/143409 [patent_app_country] => US [patent_app_date] => 2021-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19359 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17143409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/143409
Compounds for use in synthesis of peptidomimetics Jan 6, 2021 Issued
Array ( [id] => 17141602 [patent_doc_number] => 20210309614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => 5-[(PIPERAZIN-1-YL)-3-OXO-PROPYL]-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AS ADAMTS INHIBITORS FOR THE TREATMENT OF OSTEOARTHRITIS [patent_app_type] => utility [patent_app_number] => 17/141902 [patent_app_country] => US [patent_app_date] => 2021-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59946 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17141902 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/141902
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis Jan 4, 2021 Issued
Array ( [id] => 18028923 [patent_doc_number] => 11512096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Seco macrolide compounds [patent_app_type] => utility [patent_app_number] => 17/133979 [patent_app_country] => US [patent_app_date] => 2020-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58282 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2082 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133979 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/133979
Seco macrolide compounds Dec 23, 2020 Issued
Array ( [id] => 16762299 [patent_doc_number] => 20210107880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-15 [patent_title] => FORMATION OF N-PROTECTED 3,6-BIS-(4-AMINOBUTYL)-2,5-DIKETOPIPERAZINE THROUGH A CYCLIC ALPHA-N-PROTECTED AMINO ESTER [patent_app_type] => utility [patent_app_number] => 17/130729 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17130729 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/130729
Formation of N-protected 3,6-bis-(4-aminobutyl)-2,5-diketopiperazine through a cyclic a-N-protected amino ester Dec 21, 2020 Issued
Array ( [id] => 16913819 [patent_doc_number] => 20210186911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => METHODS OF TREATING BRAIN DISORDERS [patent_app_type] => utility [patent_app_number] => 17/127075 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29086 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127075 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127075
METHODS OF TREATING BRAIN DISORDERS Dec 17, 2020 Pending
Array ( [id] => 17170246 [patent_doc_number] => 20210323916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/124852 [patent_app_country] => US [patent_app_date] => 2020-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17124852 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/124852
Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof Dec 16, 2020 Issued
Menu